Life sciences companies want to access the full power of advanced analytics while maintaining regulatory compliance and data privacy. That’s why leaders from ZS and Amazon Web Services recently came together to discuss their collaboration on cloud-based solutions to modernize the life sciences value chain and reimagine care delivery. In this article from the June 2024 issue of Innovation Magazine, they discussed how these solutions can help pharmaceutical companies:
- Extract powerful insights to enhance decision-making
- Increase operational agility and deliver improved health outcomes
- Reimagine care delivery through personalized, patient-centric experiences
“Commercial teams need faster access to actionable insights, and this is still a major struggle in the pharmaceutical industry,“ said Dennis Lauth, head of life sciences commercial strategy and solutions at AWS. “We deal with more complex data now—it’s not only first-party data from customer touch points. It’s longitudinal health data, de-identified patient data, electronic health records, claims data, real-world evidence and many other sources. All those data need to be ingested and made comprehensible. Modern business users demand agility, speed and accurate data quality to generate actionable and timely insights at their fingertips.“
ZS has long been an AWS healthcare partner and the companies look forward to continuing to innovate together, said Kapil Pant, global head of enterprise data management and analytics at ZS.
“AWS is one of our key collaborators,” Pant said. “Our complementary expertise allows us to co-develop differentiated solutions that unlock value for clients spanning the pharmaceutical value chain and broader healthcare domains.“
Read the article to hear what industry leaders have to say about improving the patient experience, AI-driven innovation in drug discovery, how technology can advance clinical trials and more.
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.
